Skip to content

Symposium 2023 Registration is now open

HFA logo
Menu
  • About HFA
    • Our Story
    • Our Team
    • Our Board
    • Our Sponsors
  • Our Work
    • Assisting
    • Educating
    • Advocating
  • Learn
    • History of Bleeding Disorders
    • Bleeding Disorders 101
    • Learning Central
  • Financial Assistance
    • Helping Hands
      • Emergency Assistance
      • Items Assistance
      • Inhibitor Support
      • Disaster Relief
    • Job Readiness Grants
    • Scholarships
  • Get Connected
    • Join Blood Sisterhood
    • Join Blood Brotherhood
    • Join Sangre Latina
    • Contact Your Legislator
    • Apply for an Internship
    • Become a Member
  • Locate
    • Member Organizations
    • Hemophilia Treatment Centers
    • Summer Camps
  • Resources
  • Events
    • All Events
    • Symposium 2023
  • News
  • Donate
Search
Close

Day: October 21, 2015

FDA Approves First Factor X Concentrate for Treatment of a Rare Hereditary Bleeding Disorder

Note: The following is an edited version of a press release originally published by the US Food and Drug Administration (FDA). The original release can be read here. The U.S. Food and Drug Administration announced on Tuesday, October 20, 2015, the approval of  Coagadex, Coagulation Factor X (Human), for hereditary Factor X (10) deficiency. Until […]

Helpful Links

  • Contact HFA
  • Careers
  • DEI Statement
  • Financials & Reports
  • Funding Policies
  • Privacy Policy
Menu
  • Contact HFA
  • Careers
  • DEI Statement
  • Financials & Reports
  • Funding Policies
  • Privacy Policy

Sign up for our news and updates

Facebook Instagram Twitter Linkedin Youtube

© 2023 Hemophilia Federation of America | Site powered by HFA Staff